Jatt II Acquisition Corp:Tala-125预计2027年第一季度进入临床,中期一期数据有望于2027年第四季度公布

美股速递
Jun 29

Jatt II Acquisition Corp宣布,其研发的Tala-125预计将于2027年第一季度进入临床研究阶段。该药物的一期临床试验中期数据则有望在2027年第四季度获得。这一进展标志着公司在相关治疗领域的研发管线向前迈出了重要一步。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10